Univest
Univest
  • Markets

Quick Heal Technologies Q4 FY26 Results: Loss Rs 20 Cr

  • May 22, 2026
  • Posted by: Kashish Aggarwal
  • Category: News
No Comments
Quick Heal Technologies Q4 FY26 Results

Quick Heal Technologies Q4 FY26 results were declared on May 21, 2026. The company reported net loss of Rs 20 crore for the quarter ended March 31, 2026, down 566.7% YoY compared to loss of Rs 3 crore in Q4 FY25. Revenue from operations stood at Rs 49 crore. Results are on a Consolidated basis. Quick Heal Technologies is a Cybersecurity company listed on Indian stock exchanges.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Quick Heal Technologies Q4 FY26 Financial Highlights
  • Quick Heal Technologies Q4 FY26 Performance Analysis
  • Key Factors Driving Quick Heal Technologies Q4 FY26 Results
    • Revenue and Business Performance
    • Profitability and Margins
    • India Macro Backdrop
    • FY27 Outlook
  • Frequently Asked Questions on the company
    • What is Quick Heal Technologies Q4 FY26 net loss?
    • What is Quick Heal Technologies Q4 FY26 revenue?
    • When were Quick Heal Technologies Q4 FY26 results declared?
    • Is Quick Heal Technologies a good investment after Q4 FY26?

Quick Heal Technologies Q4 FY26 Financial Highlights

Metric Q4 FY26 (Rs Cr) Q4 FY25 (Rs Cr) YoY Change
Revenue 49 N/A N/A
Net Loss 20 3 -566.7%
Basis Consolidated

Note: Quick Heal Technologies Q4 FY26 results declared May 21, 2026. Verify from BSE/NSE audited filings before investment decisions.

Quick Heal Technologies Q4 FY26 Performance Analysis

The Quick Heal Technologies Q4 FY26 results reflect the company’s operational performance in the January to March 2026 quarter. The quarter reflects near-term profitability challenges. Quick Heal Technologies operates in the Cybersecurity sector, which benefited from India’s GDP growth above 6.5% in FY26.

Revenue of Rs 49 crore reflects steady business conditions in the Cybersecurity sector.

Screen the best stocks on the Univest Screener.

Key Factors Driving Quick Heal Technologies Q4 FY26 Results

Revenue and Business Performance

Quick Heal Technologies Q4 FY26 revenue of Rs 49 crore was for the quarter ended March 31, 2026. Revenue momentum reflects steady demand in the Cybersecurity business.

Profitability and Margins

The business net loss of Rs 20 crore is down 566.7% YoY. Margin recovery and revenue growth will be the key operational levers entering FY27.

India Macro Backdrop

The January to March 2026 quarter benefited from India’s GDP growth above 6.5%, government capital expenditure of Rs 11.21 lakh crore for FY27, and resilient domestic consumption. RBI’s accommodative stance supported credit and demand conditions. The Cybersecurity sector saw strong tailwinds during this period.

FY27 Outlook

Following the firm results, management commentary on FY27 revenue guidance, margin expansion roadmap, and capital allocation will be key investor watchpoints. The Cybersecurity sector continues to benefit from India’s long-term structural growth.

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.

Frequently Asked Questions on the company

What is Quick Heal Technologies Q4 FY26 net loss?

Ans. Quick Heal Technologies Q4 FY26 net loss of Rs 20 crore, down 566.7% YoY from loss of Rs 3 crore in Q4 FY25. Results declared May 21, 2026, on a Consolidated basis.

What is Quick Heal Technologies Q4 FY26 revenue?

Ans. Quick Heal Technologies Q4 FY26 revenue from operations was Rs 49 crore. Verify from BSE/NSE filings.

When were Quick Heal Technologies Q4 FY26 results declared?

Ans. Quick Heal Technologies Q4 FY26 results were declared on May 21, 2026, at the board of directors meeting approving audited Q4 and FY26 financial statements.

Is Quick Heal Technologies a good investment after Q4 FY26?

Ans. Investment decisions require individual assessment of fundamentals, valuation, and risk. This article is for educational purposes only. Consult a SEBI-registered financial advisor before investing.

Investments in securities are subject to market risk. This content is for educational purposes only. Verify all figures from BSE/NSE filings. Consult a SEBI-registered financial advisor.



Author: Kashish Aggarwal
Kashish Aggarwal is a Financial Content Writer at Univest, covering Indian equity markets with a focus on share price target frameworks, technical analysis education, and sector deep-dives. Her published work spans bull-case/bear-case share price analysis, event-driven stock reactions, and beginner-friendly educational guides. Her articles blend fundamental analysis (analyst consensus targets, P/E, loan book quality, margin dynamics) with technical analysis (moving averages, 200-DMA, support/resistance levels) — giving retail investors a complete framework before any position. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards. Coverage Areas • Share price targets — REC Ltd, Adani Green Energy (bull/bear case frameworks) • Event-driven analysis — Redington (US tariff impact), Star Cement (technical breakdown) • Technical analysis education — Direct Market Access, 200-DMA, indicator interpretation • Thematic listicles — Highest Dividend Paying Stocks, Real Estate Penny Stocks, Intraday Picks • Sector coverage — IT distribution, renewable energy, infrastructure finance, cement, real estate

Leave a Reply Cancel reply